David Flyer
10Patents
4h-index
9Co-inventors
53Inventor score
Filing activity: Mar 3, 1997 → Sep 9, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6316257A | "Modified rapid expansion methods (""modified-REM"") for in vitro propagation of T lymphocytes" | Chemistry; Metallurgy | 23 | Expired |
| US6890753B2 | Modified rapid expansion methods(“modified-REM”) for in vitro propagation of T lymphocytes | Chemistry; Metallurgy | 12 | Expired |
| US10357557B2 | Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereof | Emerging Cross-Sectional Technologies | 10 | Active |
| US9598472B2 | Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US10821166B2 | Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US11478540B2 | Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11123419B2 | Methods and compositions for inducing immune responses against Clostridium difficile | Chemistry; Metallurgy | 1 | Active |
| US11357844B2 | Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12324831B2 | Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11938179B2 | Methods and compositions for inducing immune responses against Clostridium difficile | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.